(in alphabetical order)

Andrew Bellizzi (USA)

Andrew M Bellizzi, M.D. is a Clinical Professor in the Department of Pathology at the University of Iowa. Dr. Bellizzi completed undergraduate work in Anthropology and Science Preprofessional Studies at the University of Notre Dame (‘00) and received his medical degree from Northwestern University (‘04).  Following combined training in Anatomic and Clinical Pathology at the University of Virginia (‘08), he completed a fellowship in Gastrointestinal and Liver Pathology at The Ohio State University (‘09). After 2 years as a junior faculty at Brigham and Women’s Hospital, he moved to Iowa in the Fall of 2011. Dr. Bellizzi is Director of Immunohistochemistry, GI Pathology, and the GI Pathology Fellowship at the University of Iowa. He is an active member of the United States and Canadian Academy of Pathology, the American Society of Clinical Pathology, and the College of American Pathologists, including serving as immediate past Chair of the USCAP Stowell-Orbison Award and the CAP Immunohistochemistry Committees. He is Secretary-Treasurer of the International Society for Immunohistochemistry and Molecular Morphology and is an Associate (Reviews), Section (Immunohistochemistry), and Assistant Editor (GI pathology) of Applied Immunohistochemistry and Molecular Morphology, Archives of Pathology and Laboratory Medicine, and the American Journal of Clinical Pathology, respectively. Dr. Bellizzi’s research interests include the diagnosis, classification, and etiopathogenesis of human disease, with an emphasis on gastrointestinal, pancreatic, neuroendocrine, and hereditary tumors. His research program focuses on applications of diagnostic immunohistochemistry. Outside of the office, Andrew enjoys “getting into trouble” with his 14 and 16-year-old boys, Aidan and Darby. In addition to “very special stains,” he also loves hiking, cooking, craft beer, Notre Dame football, the Boston Red Sox, and the Oxford comma.

Gabor Cserni (Hungary)

Studied at the Medical University of Szeged and graduated from the Albert Szent-Györgyi Medical University (same institution under different names) in 1990. Following his training at the same university and the Bács-Kiskun County Teaching Hospital (BKCTH), got board certification in pathology in 1995. Step by step, he got to the position of Head of the Department of Pathology at BKCTH in 2005. Was nominated Professor of Pathology at the University of Szeged Faculty of Medicine (the same institution as for the studies and the M.D., but under a third name) in 2011, and holds a part-time position at the University. His main field of interest is breast pathology. He is the author or co-author of nearly 350 peer-reviewed papers including a few book chapters; is an invited speaker at national or international scientific meetings; is the editorial board member in a few national / international medical or pathology journals and peer reviews 25-50 papers/year for nearly 4-5 dozen of medical journals. He is the member of several scientific societies, and is the president elect of the Hungarian Society of Pathology for 2027-2029. He likes reading, listening to music (rock, jazz, blues, classical).

Ben Davidson (Norway)

Professor at Faculty of Medicine, University of Oslo and Head of Gynecologic Pathology service, Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. He is currently Chair of the Gynecologic Pathology Working Group at the European Society of Pathology (ESP) and is member of the expert group for gynecological cancer at the European Society of Medical Oncology (ESMO). His main research interests are cytopathology and gynecological pathology. His research is focused on genetic characteristics and biomarkers related to cancer diagnosis, metastasis, cell survival, prognosis and chemoresistance in cancers involving the serosal cavities, particularly tubo- ovarian carcinoma and mesothelioma. He is an author of 385 peer-reviewed scientific publications and 15 book chapters, as well as the editor of a book on serous effusions. He is also a reviewer and a member of editorial boards for leading international peer-reviewed journals, as well as invited speaker on international and national meetings and conferences.

Pavel Dundr (Czech Republic)

Professor and Head of the Department of Pathology, 1st Medical Faculty Charles University and General University Hospital in Prague. Since 2016 he is a president of the Society of Czech Pathologists. Author and co-author of over 200 scientific papers. His research interest is mostly focused on gynecopathology, molecular pathology and immunohistochemistry.

Maria Debiec-Rychter (Belgium)

Is a professor emeritus at the Department of Human Genetics, KU Leuven, Belgium. In the past, her scientific interest was focused on the development and transfer of the knowledge of genetic origin and molecular features of solid tumors (mainly sarcomas and brain neoplastic entities) to the daily medical practice, aiming at improvement of diagnostic, prognostic and predictive tools, identification of new therapeutic targets, and promotion of innovative clinical trials in order to evaluate these new targets. She is an author and co-author of 319 publications in peer reviewed journals.

M. Karmal (France)

Maud Kamal, PhD is the scientific manager of the department of Drug Development and Innovation (D3i) at Institut Curie. She heads the scientific coordination unit in charge of the research activity of the department including national & international programs related to precision medicine. She is also the scientific manager of Institut Curie Molecular Tumor Board (MTB) and the National MTB for Cancer of Unknown Primary.

Following a BSc and a Teaching Diploma in Sciences from the American University of Beirut, Lebanon, in 1999, she received a scholarship for a PhD program in molecular and cell biology from the University of Sherbrooke, Canada. After receiving her MSc in Cell Biology, she pursued her PhD studies in Molecular and Cellular Biology at the University of Paris XII in France. She also holds a University Diploma in « Economic Valorisation of Research » from University of Paris VI. Maud Kamal has published >90 peer-reviewed papers in international journals (h-Index 42, Citations 6224).

Jan Klos (Norway)

Senior Consultant in the Department of Pathology, Stavanger University Hospital, Norway. His professional focus is on diagnostic pathology, particularly hematopathology, pathology of the breast and cytopathology. He has been actively involved in teaching immunohistochemistry since 2000 as co-organizer of national and international meetings and courses as well as invited speaker. Since 2009 he is a member of the core group and assessor in NordiQC organization. He is a co-author of more than 40 publications in the field of pathology.

Konstanty Korski (Germany)

Konstanty Korski is a Senior Expert Pathologist and R&D Lead for Digital Pathology in the Roche pharma personalised healthcare (phc) Data, Analytics & Imaging group in Basel, Switzerland. He graduated from the Poznan University of Medical Sciences (2001) and is board certified in general pathology (2008). Since his graduation, he served as a staff pathologist in the Pathology Department at the Greater Poland Cancer Center in Poznan, Poland, where his main focus was breast and gynecologic pathology, cytopathology, immunohistochemistry and molecular pathology. At that time, in one of his roles he coordinated tumor sample collection process in the collaborative international effort – The Cancer Genome Project (TCGA). Konstanty joined Roche in 2014 at the Roche Innovation Centre Munich where he focused on the application of digital pathology to tumor tissue analysis and immune microenvironment characterization in the context of early phase clinical trials. In 2020, Konstanty joined the phc group in Basel where he leads the R&D DP team. The team concentrates on the extraction of information from the digital images of the H&E slides and on translating it to predictive/prognostic algorithms using state-of-the-art machine learning techniques. Konstanty co-authored more than 30 peer reviewed publications and three patent applications.

Adam Kowalewski (Poland)

Adam Kowalewski is a pathologist in training at the Prof. F. Łukaszczyk Oncology Center in Bydgoszcz, Poland, and an Assistant Professor at the University of Science and Technology, Bydgoszcz, Poland. He is currently pursuing a European Masters in Molecular Pathology at the University Côte d’Azur in Nice, France. Adam has honed his skills through international internships and training programs at Institut Curie, Massachusetts Institute of Technology, Harvard Medical School, and the University of Minnesota.  Adam has made contributions to the field of pathology by co-authoring national guidelines and leading research projects focusing on cancer diagnostics and tumor evolution, with several projects co-financed by the European Union and Adamed Pharma. He holds three patents in minimally invasive cancer diagnostics and was a finalist in the MIT Enterprise Forum CEE Accelerator, where he also secured the Audience Award.  He has presented his research findings at many international congresses and has co-authored over 20 publications in peer-reviewed journals as well as a book chapter. Adam has received academic and professional recognition, including two scholarships from the Ministry of Science and Higher Education. He is an editorial board member for Frontiers in Oncology, specializing in the Genitourinary Oncology section.

Jerzy Lasota (USA)

Staff Scientist at the Surgical Pathology Section of the Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland. Previously at the Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, D.C., Thomas Jefferson University and Temple University’s Fels Institute for Cancer Research and Molecular Biology in Philadelphia, as a Research Pathologist and in the Molecular Diagnostic Laboratory. He is an author and co-author of 130 publications, including studies on genotyping gastrointestinal stromal tumours and several book chapters on molecular genetics of soft tissue tumors.

Iwona Ługowska (Poland)

Prof Iwona Lugowska is a clinical oncologist, Plenipotentiary Director for International Affairs, Head of the Early Phase Clinical Trials Unit, Leader of the Centre of Excellence for Precision Oncology at the Maria Skłodowska Curie National Research Institute of Oncology, Warsaw, Poland. Prof. Lugowska is also the Executive Secretary and Board Member of the Organisation European Cancer Institutes (OECI), the Chair of the European Society for Medical Oncology (ESMO) Educational Publications Working Group, and the Republic of Poland representative in EU activities related to Mission Cancer. She is a member of Steering Committee of the European Reference Network on Rare Adult Cancers (EURACAN-ERN) being responsible for Guideline Development in Rare Cancers. Recently she has been appointed as a leader of European Network of Expertise for Poor Prognosis Cancers within EU JA-JANE initiative.
Prof. Lugowska has completed fellowships/training at the Memorial Sloan Kettering Cancer Center, USA; the Sir Bobby Robson Cancer Trials Research Centre, Newcastle upon Tyne, UK; and the Agostino Gemelli Hospital, Catholic University of the Sacred Heart, Rome, Italy. Her main fields of interest are precision oncology and early drug development for solid tumours.

Anais Malpica (USA)

Dr. Anais Malpica is a Professor of Pathology at The University of Texas M.D. Anderson Cancer Center in Houston, Texas. She received her M.D. degree from the Universidad Central de Venezuela in Caracas, Venezuela, and completed both Anatomic and Clinical Pathology residencies at Boston University and Baylor College of Medicine. This was followed by a fellowship in Surgical Pathology at The University of Texas M.D. Anderson Cancer Center. She was the former Director of the Gynecologic Pathology Section (2006-2014and Director of the Gynecologic Pathology Fellowship Program (2003-2013)at MD Anderson. Dr. Malpica has authored and co- authored 275 scientific articles, 184 abstracts, numerous book chapters and 1 book on biopsy interpretation of the uterine cervix and corpus (2 editions). She is a member of the editorial board of the International Journal of Gynecological Pathology and a former member of the editorial board of Archives of Pathology and Laboratory Medicine and Gynecologic Oncology. She is currently a reviewer for Histopathology, Cancer, Advances of Anatomic Pathology, Modern Pathology, Gynecologic Oncology and other journals. She was an author and editor of the 2020 WHO Classification of Female Genital Tract Tumours. She is a former Co-chair of the Educational Committee of the International Society of Gynecologic Pathology (2014-2016), and a former member of the Endometrial Cancer Task Force (2017-2018) and the Endocervical Cancer Task Force (2019-2020) of the International Society of Gynecologic Pathology. She has been involved in multiple funded research projects as a Co-investigator or collaborator. Dr. Malpica has organized numerous seminars and conferences about gynecologic pathology throughout the world and has given over 400 lectures in local, national and international meetings, including the United States and Canadian Academy of Pathology, the CAP, the ASCP, the European Congress of Pathology, the International Academy of Pathology, the Latin American Congress of Pathology, the German Congress of Pathology, the Canadian Association of Pathologists, etc. She has been an invited lecturer at numerous universities in the United States, Europe, Latin America, the Middle East, and Asia.

Markku Miettinen (USA)

Professor and Head of Surgical Pathology, National Cancer Institute, Bethesda, Maryland, previously at Armed Forces Institute of Pathology, Washington DC and Thomas Jefferson University, Philadelphia, USA. His main interest is pathology of soft tissues. His contribution to definition, biology and diagnosis of Gastrointestinal Stromal Tumors is well recognized. He is a member of editorial boards in several top ranked pathology journals and reviewer in a number of most recognized pathology journals. His list of publications has more than 350 positions including two handbooks on Pathology of Soft Tissues and contributions to WHO Classification of Tumours of Soft Tissue and Bone. In recognition of his work honored with Totten Lecture and Award, University of Pittsburgh in 2005.

Andrew Nicholson (Great Britain)

Professor Nicholson is an expert in thoracic pathology, receiving the Mary J. Matthews award for Lifetime Scientific Achievement in lung cancer translational research in 2019. He is a past chair of the International Association for the Study of Lung Cancer (IASLC) Pathology Committee, and Past President of the British Division of the International Academy of Pathologists. He has co-authored Pathology of the Lung (2011), the AFIP Atlases of Tumors of the Lower Respiratory Tract (2019) and Serosal Membranes (2022), was an Editor/Expert Member of the 2015 and 2021 WHO classifications of thoracic tumours, and has co-authored over 500 peer-reviewed publications.

Søren Nielsen (Denmark)

Søren Nielsen is Director of Nordic immunohistochemical Quality Control (NordiQC) being an international external quality assessment (EQA) scheme for diagnostic pathology laboratories. In addition to the EQA scheme, NordiQC offers technical and educational service to laboratories and IHC stakeholders globally and have entered collaboration with the main IHC industry companies for consultancy services. In NordiQC, he also functions as scientific lead, assessor and data analyst in the NordiQC general module, breast module, companion diagnostic module and HER-2 ISH module. He is a regular lecturer and organizer of national and international immunohistochemical workshops, particularly in the field of protocol optimization and standardization. He is author and co-author of more than 80 scientific papers and several book chapters based on immunohistochemical studies. Member of the editorial board of international journals, board of consortium of analytical standardization of immunohistochemistry and the NordiQC representative in IQN Path, being a global network for external quality schemes in pathology. Søren Nielsen is educated as biomedical scientist.

Janusz Rys (Poland)

Graduated from Medical Faculty Jagiellonian University (1984), board certified pathologist (1991). Since 2002 is Head of Department of Tumor Pathology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute and Centre of Oncology, Kraków, Poland. Since Februar 2021, he is also the director of the M. Sklodowska-Curie National Research Institute of Oncology, Cracow Branch. Author and co-author of over 195 articles published, most of them concerning breast and soft tissue pathology. Editor in chief of the Polish Journal of Pathology.

Hans-Ulrich Schildhaus (Germany)

Professor of Molecular Tumor Pathology and Head of the Molecular Pathology Laboratory at the Institute of Pathology, authorized representative for Personalized Medicine at the University Medical Center, Georg August University, Göttingen, Germany. He is also a reviewer for international journals such as the Journal of Pathology, Oncotarget, Virchows Archive, Cancer Research etc. as well as an invited speaker and lecturer of the International Academy of Pathology (IAP) in the areas of molecular pathology, fluorescence in situ hybridization and soft tissue tumors. He is also co-author of more than 100 publications in pathology. His major scientific interest is focused on lung cancer, sarcomas and the development of predictive biomarkers.

K. Tałasiewicz (Poland)

Konrad Tałasiewicz serves as the deputy head of the Department of Oncology Diagnostics, Cardiooncology, and Palliative Medicine at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland. His primary focus within the department lies in cancer of unknown primary (CUP) and cancer diagnostics. He obtained his medical degree from the Medical University of Gdansk in 2011 and holds board certification in clinical oncology since 2018, along with certification from the European Society of Medical Oncology in the same year. Tałasiewicz has presented his research, particularly in the area of cancer of unknown primary, at numerous international congresses and has contributed to over 10 publications in peer-reviewed journals within the field. His key interests revolve around CUP, precision oncology and cancer diagnostics.

Tibor Tot (Sweden)

Tibor Tot (Sweden) is associate professor of pathology at the University of Uppsala and former head of Laboratory Medicine Dalarna and of the Department of Pathology and Clinical Cytology at the County Hospital in Falun, Sweden. The last years he was one of the faculty members in the breast pathology arm of the European School of Pathology, invited faculty member in European School of Radiology and one of the scientific directors in the European School of Oncology Certificate of Competence in Breast Cancer program. In addition to more than 100 journal articles and 20 book chapters, he published the book Practical Breast Pathology, an official teaching material of the European School of Pathology. He is also co-author of the Thieme Series on Art and Science of Mammography. With radiological – pathological correlation of breast diseases as the main field of interest, he is repeatedly invited lecturer at the European Congress of Radiology, European Congress of Pathology, and other international and national congresses, symposia, and teaching courses all over the world. He is a member of the Editorial Board of Virchows Archiv,  of Vojnosanitetski pregled (Belgrade), the Journal of OncoPathology, Materia Medica (Belgrade), and the Journal of Solid Tumors, one of the editors of the European Journal of Breast Health and of the Case Reports in Pathology. He is member of the European Working Group for Breast Cancer Screening Pathology and the past chair of the Working Group for Breast Pathology of the European Society of Pathology.